Trademark: 87836344
Word
THE CURA GROUP
Status
Dead
Status Code
602
Status Date
Monday, January 28, 2019
Serial Number
87836344
Mark Type
4000
Filing Date
Thursday, March 15, 2018
Abandoned Date
Thursday, January 3, 2019

Trademark Owner History

Classifications
1 Chemicals used in industry and science; extraction reagents for scientific or research use; chemical reagents and buffers for scientific or research use; reagents for next generation sequencing (NGS) library preparation for scientific and research use
9 Computer software for use in medical diagnostics, medical image analysis, medical screening, medical testing, DNA screening for medical purposes, and genetic testing for medical purposes; computer software for the analysis of medical data, namely, medical imaging data, health care data, health records, medical records, and genomic data for use in the prevention, diagnosis and treatment of medical conditions, analyzing clinical trials, analyzing drug interactions, development of vaccines and medicines, medical diagnostics, molecular medicine, precision medicine, and structural and functional analysis of genomes; computer software for the analysis of genomic data for use in tracking variation and mutation of pathogens; computer software for determining and predicting patterns in data, namely, medical data, genomic data, proteomic data, metabolomics data, transcriptomic data, nutritional and nutrigenomics data, medical imaging data, health care data, health records, medical records, genomic data, and environmental factor data; computer software for executing preconfigured non-field specific machine learning and deep learning algorithms and processes for the purposes of uploading and managing data for the training of preconfigured data models implemented on a hosted software platform utilizing said machine learning and deep learning processes and for utilizing said trained data models for use in medical diagnostics, medical image analysis, medical screening, medical testing, DNA screening for medical purposes, and genetic testing for medical purposes; computer software for conducting natural language processing on medical records to transform unstructured data into structured data supporting clinical and research use
35 Business logistics management in the field of collection, laboratory processing, storage, inventorying, retrieval and transport of biological specimens obtained for use in genomic sequencing
42 Providing software as a service (SaaS) for use in medical diagnostics, medical image analysis, medical screening, medical testing, DNA screening for medical purposes, and genetic testing for medical purposes; providing software as a service (SaaS) for the analysis of medical data, namely, medical imaging data, health care data, health records, medical records, and genomic data for use in the prevention, diagnosis and treatment of medical conditions, analyzing clinical trials, analyzing drug interactions, development of vaccines and medicines, medical diagnostics, molecular medicine, precision medicine, and structural and functional analysis of genomes; providing software as a service (SaaS) for the analysis of genomic data for use in tracking variation and mutation of pathogens; providing software as a service (SaaS) for determining and predicting patterns in data, namely, medical data, genomic data, proteomic data, metabolomics data, transcriptomic data, nutritional and nutrigenomics data, medical imaging data, health care data, health records, medical records, genomic data, and environmental factor data; providing software as a service (SaaS) for executing preconfigured non-field specific machine learning and deep learning algorithms and processes for the purposes of uploading and managing data for the training of preconfigured data models implemented on a hosted software platform utilizing said machine learning and deep learning processes and for utilizing said trained data models for use in medical diagnostics, medical image analysis, medical screening, medical testing, DNA screening for medical purposes, and genetic testing for medical purposes; providing software as a service (SaaS) for conducting natural language processing on medical records to transform unstructured data into structured data supporting clinical and research use; research, development, testing, and deployment of immunotherapy drugs; Platform as a service (PAAS) featuring computer software platforms for clinical decision support for patient care; providing scientific analysis in the field of next generation sequencing (NGS), namely, the analysis and interpretation of genomic data
44 molecular diagnostic services for medical and research purposes; medical testing for the detection of genetic information pertaining to human disease; medical diagnostic testing services in the field of human disease and human medical conditions; medical testing for diagnostic or treatment purposes; providing medical information to others in the field of human disease, human medical conditions, medical diagnostic testing services and medical testing for diagnostic or treatment purposes; providing an Internet website portal featuring medical information in the field of human disease, and human medical conditions, medical diagnostic testing services, medical testing for diagnostic or treatment purposes; Medical diagnostic testing to aid in diagnosis, prognosis and therapy selection; Health care services, namely, medical laboratory services and clinical laboratory services for testing clinical specimens for the purpose of providing information for health assessment and for the diagnosis, prevention, or treatment of disease; Health care services, namely, medical laboratory services and clinical laboratory services for testing clinical specimens for the purpose of providing information for medical research, clinical trials, and pre-clinical investigations

Trademark Events
Jan 28, 2019
Abandonment Notice E-Mailed - Failure To Respond
Jan 28, 2019
Abandonment - Failure To Respond Or Late Response
Jul 2, 2018
Notification Of Non-Final Action E-Mailed
Jul 2, 2018
Non-Final Action E-Mailed
Jul 2, 2018
Non-Final Action Written
Jun 26, 2018
Assigned To Examiner
Mar 22, 2018
New Application Office Supplied Data Entered In Tram
Mar 19, 2018
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24